Stevens Johnson Syndrome Toxic Epidermal Necrolysis Overlap Triggered by Paracetamol and Exacerbated by Cephalosporin and Fluorokuinolon: A Case Report
Downloads
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but life-threatening type IV hypersensitivity reactions, characterized by epidermal necrolysis, bules, skin desquamation, and mucosal involvement. Most cases are triggered by medications, with a fairly high mortality rate, especially in TEN. Management requires discontinuation of trigger medications as early as possible, a multidisciplinary approach, and intensive supportive therapy. It was reported that a 40-year-old Russian man with complaints of peeling skin almost all over the body, pain, burning sensation, accompanied by eye and lip disorders. Complaints arise after the consumption of paracetamol and worsen after the administration of ceftriaxone and levofloxacin. Physical examination showed extensive skin and mucosal involvement with a positive Nikolsky mark, BSA 32%. Laboratory tests showed leukocytosis and increased CRP. The diagnosis of SJS is established with the suspected cause of these drugs. Patients receive supportive therapy including antibiotic discontinuation, rehydration, corticosteroids, antihistamines, mucosal protection, wound care, as well as consultations with ophthalmologists and ENTs. The management of SJS requires discontinuation of trigger drugs as early as possible, intensive supportive therapy, and multidisciplinary coordination to reduce complications and mortality.
Copyright (c) 2025 Retno Niken Hapsari, Marina Haroen

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.






